Yekta Altemur KARAMUSTAFAOĞLU, Yener YÖRÜK, Taner TARLADAÇALIŞIR, Sedat KOÇAL, Sevinç TİRYAKİ YAĞCI, İrfan ÇİÇİN

Implantations of Central Venous Ports with Chest Catheter Insertion Via the Subclavian Vein in Oncology Patients: A Single Çenter Experience

Bu çalışmada amaç uzun dönem damar yolu açıklığının sağlanması; beslenme veya kemoterapi gereken erişkin onkoloji hastalarında göğüs duvarına implante edilebilir port kateterin güvenlik, uygunluk, konfor ve komplikasyonlarının değerlendirilmesidir. 01 Kasım 2006-15 Şubat 2009 tarihleri arasında 132 hastaya subklavyen ven yoluyla port kateter yerleştirildi. Bu 132 hastanın, 61 (%46)'i erkek ve 71 (%>54)'i kadındı. Ortalama yaşları 55.8 (18-86) idi. Kateterin ortalama kalış süresi 255 gün (301150 kateter günü) olarak belirlendi, işleme ilişkin 21 (%15.5) komplikasyon oluştu (beş pnömotoraks, beş yara yeri enfeksiyonu, dokuz arter ponksiyonu, bir kateter tıkanması, bir kateterin koparak kırılması). İşleme bağlı erken komplikasyon oranı %10.3 ve geç komplikasyon oranı %5.1 olarak kaydedildi. Kateter iki hastada infeksiyon ve bir hastada koparak kırılma nedeniyle çıkartıldı. Kateter hastaların büyük çoğunluğunda (n =129, %97.8) fonksiyonel olarak çalışmaktadır. Subklavyen ven yolu ile tamamen implante edilebilir venöz port takılması işlemi kemoterapi ve beslenme için güvenli ve konforlu bir yoldur. Bununla birlikte, potansiyel ciddi komplikasyonları ve kozmetik sıkıntıları da beraberinde getirebilmektedir.

Anahtar Kelimeler:

Venöz port, onkoloji, subklavyen ven, komplikasyon.

Onkoloji Hastalarında Göğüs Duvarı Yerleşimli Santral Venöz Kateter Uygulamaları: Tek Merkez Deneyimi

Evaluation of safety, comfortability and reliability of implantable venous port catheter insertion via the subclavian vein in oncology patients and complications of subcutaneous venous chest ports in adult patients. Port catheter was inserted in 132 patients via subclavian vein, from November 01, 2006 to February 15, 2009. Of the 132 patients, 61 (46%) were men and 71 (54%) were women. The mean age was 55.8 (range: 18-86). Mean duration of cathetere stay was 255 days (range: 30-1150 catheter days). in 21 (15.5%) procedures, the foitowing related complications occured (pneumothorax in five, infections in five, arteriai punctu-res in nine, obstruction in one, breakage of catheter in one). Procedure related early complication rate was 10.3%, and late complications occured at a rate of 5.1 %. Catheter removai was required in three patients due to two catheter infections and one spon-taneous breakage of the catheter. İn the vast majority 97.8% n =129) of the patients the device has stili been functioning nor-mally. The results indicate that the use of a totally implantable venous access system insertion via subclavian vein is a comfor-table and reliable method for chemotherapy administration and nutrition. Hovvever, Central venous catheters are associated with a number of potentially serious complications and can be cosmetically distressing.

Keywords:

Venous port, oncology, subclavian vein, complication.,

PDF

___

NiderhuberJE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982;92:706-12.
Gebauer B, Teichgraber UK, Podrabsky P, Werk M,
Hanninen EL, Felix R. Radiological interventions for correc- tion of Central venous port catheter migration. Cardiovasc fntervent Radiol 2007;30:216-21.
Yip D, Funaki B. Subcutaneous chest ports via the internal jugular vein. A retrospective study of 117 oncology patients. Açta Radiol 2002;43:371-5.
Povoski SP. Cephalic vein cutdovvn approach for chronic indwelling controi venous access. Arch Surg Oncol 2000; 7:496-502.
De Gregorio MA, Migueiena JM, Fernandez JA, De Gregorio C, Tres A, Alfonso ER. Subcutaneous ports in the radiology süite. An effective and safe procedure for çare in cancer patients. Eur Radiol 1996;6:748-52.
Evans TR, Lofts FJ, Mansi JL, Glees JP, Dalgleish AG, Knight MJ. A phase II study of continuous infusion 5 fluora- cil vvith cisplatin and epirubicin in inoperable pancreatic can cer. B rJ Cancer 1996;73:1260-4.
Funaki B, Szymski GX, Hackworth C, et al. Radiologic pla cement of subcutaneous infusion chest ports for long-term Central venous access. AJR Am J Roentgenoi 1997;169:1431-4.
Charvat J, Linke Z, Horaekova M, Prausova J. İmplantation of Central venous ports vvith catheter insertion via the right internal jugular vein in oncology patients: Single çenter experience. Support Çare Cancer 2006;14:1162-5.
Kock HJ, Pietsch M, Krause U, VVİlke H, Eigler FW. İmplantable vascular access system. Experience in 1500 patients vvith totally implanted Central venous port system. WorldJ Surg 1998;22:12-6.
Cil BE, Canyigit M, Peynircioğlu B, Hazirolan T, Carkaci S. Subcutaneous venous port implantation in adult patients. A single çenter experience. Diagn Interv Radiol 2006;12:93-8.
Ng F, Mastoroudes H, Paul E, et al. A comprasion of Hickman line and port-a-cath associated complications in patients vvith solid tumours undergoing chemotherapy. Clin Oncol (R Coll Radiol) 2007;19:551-6.
Mansfield PF, Hohn DC, Fornage BD, Gregurich MA, Ota DM. Complication and failure of subclavian vein catheteri- zation. N Engl J Med 1994;331:1735-8.
Teichgraber UK, Gebauer B, BenterT, WagnerJ. Long term Central venous lines and their complications. Rofo 2004;176:944-52.
Yildizeli B, Lacin T, Batirel HF, Yüksel M. Complication and management of long term Central venous access catheters and ports. J Vasc Access 2004;5:174-8.
Vescia S, Baumgartner AK, Jacobs VR, et al. Management of venous port Systems in oncology: A revievv of current evi- dence. Ann Oncol 2008;19:9-15.
Pegues D, Axelrod P, McClarren C, et al. Comprasion of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992;49:156-62.
Savader SJ, Trerotola SO. Venous interventionai radiology vvith clinical perspectives, thieme medical, Nevv York 2000.
Lorch H, Zvvaan M, Kagel C, Weiss HD. Central venous access ports placed by interventionai radiologists experien- ce vvith 125 consecutive patients. Cardiovasc Intervent Radio 2001;24:180-4.
Stanİslav GV, Fitzgibbons RJ Jr, Bailey RT Jr, Mailliard JA, Johnson PS, Feole JB. Reliability o f implantable Central venous access devices in patients vvith cancer. Arch Surg 1987;122:1280-3.
Rubenstein RB, Aiberty RE, Michels LG, Pederson RW, Rosenthal D. Hickman catheter separation. JPEN J Parenter Enteral Nutr 1985;9:754-7.